AI Verdict
RIVN has stronger fundamentals based on our AI analysis.
RLAY vs RIVN Fundamental Comparison
| Metric | RLAY | RIVN |
|---|---|---|
| Revenue | $15.4M | $5.4B |
| Net Income | $-276.5M | $-3.6B |
| Net Margin | -1,800.6% | -67.7% |
| ROE | -48.8% | -79.4% |
| ROA | -44.5% | -24.5% |
| Current Ratio | 22.61x | 2.33x |
| Debt/Equity | 0.00x | 0.97x |
| EPS | $-1.61 | $-3.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLAY vs RIVN: Frequently Asked Questions
Is RLAY or RIVN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RIVN has stronger fundamentals. RLAY is rated SELL (78% confidence) while RIVN is rated SELL (80% confidence). This is not investment advice.
How does RLAY compare to RIVN fundamentally?
Relay Therapeutics, Inc. has ROE of -48.8% vs Rivian Automotive, Inc. / DE's -79.4%. Net margins are -1,800.6% vs -67.7% respectively.
Which stock pays higher dividends, RLAY or RIVN?
RLAY has a dividend yield of N/A or no dividend while RIVN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLAY or RIVN for long term?
For long-term investing, consider that RLAY has SELL rating with 78% confidence, while RIVN has SELL rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLAY vs RIVN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLAY vs RIVN, the AI consensus favors RIVN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.